Logo

Christoph Westphal

Jul 13, 2006
Premium

Sirtris Pharmaceuticals said that it's CEO, Christoph Westphal, has been named the Ernst & Young New England Entrepreneur of the Year in the biopharmaceutical field.

Westphal is a co-founder of Alnylam Pharmaceuticals, and previously was a partner at Alnylam investor Polaris Venture Partners.

Filed under

Gene Silencing/Gene Editing
RNAi
Breaking News
The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.